Roquefort Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ROQ?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	1,174,209	0.909%
Private Companies	10,041,962	7.78%
Institutions	29,844,679	23.1%
General Public	33,891,922	26.2%
Individual Insiders	54,197,226	42%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 65.92% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.03%	Trevor Reginald	11,663,051	UK£460.7k	0%	no data
6%	Abdelatif Lachab	7,750,000	UK£306.1k	0%	no data
5.65%	Glenn Whiddon	7,300,000	UK£288.3k	0%	no data
4.45%	Mubasher Sheikh	5,744,870	UK£226.9k	0%	no data
4.35%	Stephen West	5,616,501	UK£221.9k	0%	no data
3.72%	Lyramid Limited	4,800,000	UK£189.6k	0%	no data
3.39%	Peel Hunt LLP., Asset Management Arm	4,384,615	UK£173.2k	-2.92%	0.06%
3.11%	Zita Sheikh	4,018,910	UK£158.7k	0%	no data
3.1%	Mark Rollins	4,000,000	UK£158.0k	0%	no data
3.02%	Kathryn Fallon	3,905,215	UK£154.3k	0%	no data
2.79%	Hobart Capital Markets Limited, Asset management Arm	3,600,000	UK£142.2k	-21.7%	1.25%
2.78%	BNY Mellon Advisors, Inc.	3,595,500	UK£142.0k	0%	no data
2.12%	Neue Bank Ag, Asset Management Arm	2,740,000	UK£108.2k	0%	0.12%
1.74%	Chaim Hurvitz	2,249,300	UK£88.8k	0%	no data
1.7%	James Brearley & Sons Ltd.	2,200,215	UK£86.9k	0%	0.04%
1.38%	Wrightwood Investments Limited	1,785,715	UK£70.5k	0%	no data
1.21%	IG Group Holdings Plc, Asset Management Arm	1,566,415	UK£61.9k	0.93%	0.01%
1.16%	Darrin Disley	1,495,901	UK£59.1k	0%	no data
0.83%	Method Investments & Advisory Limited, Asset Management Arm	1,071,739	UK£42.3k	-25.9%	0.21%
0.77%	Newlords Limited	1,000,000	UK£39.5k	0%	no data
0.77%	Daiichi Sankyo Company Ltd	994,780	UK£39.3k	0%	no data
0.75%	HBOS Investment Fund Managers Limited	970,199	UK£38.3k	6.88%	no data
0.72%	Lloyds Banking Group plc	936,224	UK£37.0k	0%	no data
0.69%	Barclays Bank PLC, Wealth and Investment Management Division	887,704	UK£35.1k	-10.4%	no data
0.67%	Close Asset Management Limited	859,317	UK£33.9k	2,070%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 13:06
End of Day Share Price	2024/12/23 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Roquefort Therapeutics plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution